NxThera Announces Presentation Of Sexual Function Data At The 2016 Annual Meeting Of The AUA

NxThera, Inc. announced today that the sexual function preservation data from the Company’s pivotal IDE trial, which previously established the safety and effectiveness of the Rezūm system to treat benign prostatic hyperplasia (BPH), was presented at the 2016 American Urological Association (AUA) annual meeting in San Diego today.